Rapid Therapeutic Science Laboratories (RTSL) Form 3/A Rapid Therapeutic Science Laboratories / Donal Ray Jr. Schmidt ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Schmidt Donal Ray Jr.

(Last) (First) (Middle)

5580 PETERSON LANE

SUITE 200

(Street)

DALLAS TX 75240

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/15/2020

3. Issuer Name and Ticker or Trading Symbol
Rapid Therapeutic Science Laboratories, Inc. [ RTSL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
President and CEO

5. If Amendment, Date of Original Filed (Month/Day/Year)
11/27/2020

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	140,000,000(1)	I	See Footnote(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The table above represents the ownership of shares of Texas MDI, Inc. (TMDI) as of the date Mr. Schmidt was required to file this Form 3, November 15, 2019 (the date Mr. Schmidt was appointed as director and CEO of the Issuer), and does not reflect the current ownership of TMDI as of the date of this filing, which will be disclosed in a separate Form 4.

2. Shares are held by Texas MDI, Inc. (TMDI). Donal R. Schmidt Jr. is the founder and President of TMDI, and has voting and dispositive control over the shares of the Issuer's common stock held by TMDI.

	Donal R. Schmidt	01/25/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.